Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03737656Phase 1Completed
Phase 1, randomised, open-label trial of progesterone in menopause (3 arms), sponsored by Grünenthal GmbH. Primary endpoints: Progesterone pharmacokinetic parameters (AUC0-t), Progesterone pharmacokinetic parameters (AUC0-inf) and 1 more. Started Nov 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03737656.